0001493152-23-011249.txt : 20230406
0001493152-23-011249.hdr.sgml : 20230406
20230406162035
ACCESSION NUMBER: 0001493152-23-011249
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230404
FILED AS OF DATE: 20230406
DATE AS OF CHANGE: 20230406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morse Robert A. Jr.
CENTRAL INDEX KEY: 0001960049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 23806452
MAIL ADDRESS:
STREET 1: 711 STEWART AVENUE
STREET 2: SUITE 200
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0407
4
2023-04-04
0
0000868278
ProPhase Labs, Inc.
PRPH
0001960049
Morse Robert A. Jr.
711 STEWART AVE,
SUITE 200
GARDEN CITY,
NY
11530
0
1
0
0
CHIEF FINANCIAL OFFICER
0
Option (right to buy)
9.00
2023-04-04
4
A
0
50000
0.00
A
2031-04-03
Common Stock
50000
50000
D
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in five equal annual installments beginning April 5, 2024, subject to the Reporting Person's continued employment with the Issuer on each vesting date.
/s/ Robert Morse
2022-04-06